Last reviewed · How we verify

NCT02941198

Postpartum Immediate Contraception in Cesarean Deliveries-Comparison of Two Intrauterine Systems

Completed NA Last updated 3 January 2018
What this trial tests

NA trial testing GyneFix in Intrauterine Systems in 140 participants. Completed in 31 January 2017.

Timeline
1 June 2016
Primary endpoint
31 January 2017
31 January 2017

Quick facts

Lead sponsorZeynep Kamil Maternity and Pediatric Research and Training Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment140
Start date1 June 2016
Primary completion31 January 2017
Estimated completion31 January 2017
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Zeynep Kamil Maternity and Pediatric Research and Training Hospital

Who can join

Adults 18 to 50, female only, with Intrauterine Systems or Postpartum Immediate Contraception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare two intrauterine systems in order to avoid complications originating from short pregnancy interval and undesired pregnancies in the early postpartum period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intrauterine Systems

Currently open trials in the same condition.

Other Zeynep Kamil Maternity and Pediatric Research and Training Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02941198.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing